Cite
HARVARD Citation
Kawahara, T. et al. (2022). Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors. International journal of urology. pp. 741-747. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kawahara, T. et al. (2022). Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors. International journal of urology. pp. 741-747. [Online].